|
|
||||||||
Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115
| |
ABSTRACT |
|---|
|
|
|---|
PDZ domain-containing proteins such as SAP97 and ZO-1 have been implicated in the targeting and clustering of ion channels. We have explored the interactions of these polypeptides with a cardiac voltage-gated potassium channel. Immunocytochemistry in cardiac myocytes revealed colocalization of SAP97 and Kv1.5, both at the intercalated disks and the lateral membranes. Transient transfection experiments in COS-7 cells revealed that SAP97 and Kv1.5 polypeptides formed perinuclear clustered complexes that could be coimmunoprecipitated. Mutation of the three COOH-terminal amino acid residues of Kv1.5 (T-D-L to A-A-A) abolished these interactions. Whereas in most COS-7 cells the SAP97-Kv1.5 complexes were retained in the ER, functional analyses in Xenopus oocytes showed that Kv1.5-encoded outward potassium currents were augmented by coexpression with SAP97. By contrast, cotransfected ZO-1 and Kv1.5 polypeptides in COS-7 cells could not be coprecipitated nor did the coinjection of ZO-1 augment the Kv1.5-encoded currents in oocytes. Collectively, our results suggest that SAP97 may play an important role in the modulation of Kv1.5 channel function in cardiac myocytes.
cardiac myocytes; K+ channels; ZO-1
| |
INTRODUCTION |
|---|
|
|
|---|
THE ELECTRICAL PROPERTIES of cardiac myocytes are determined to a large extent by the expression of voltage-gated potassium channels. The organization of these channels on the cell surface and their subcellular localization allow cells to increase the efficiency of their response to extracellular signals. More than 70 PSD-95/Dlg/ZO-1 (PDZ) domain-containing proteins have been described and their interactions with membrane receptors, ion channels, and other signaling proteins have been elucidated (11). The name PDZ derives from the three proteins that contain this domain: the mammalian postsynaptic density protein-95 kDa (PSD-95), the Drosophila disk large tumor suppressor Dlg, and the mammalian tight junction protein ZO-1 (12, 21). Proteins possessing PDZ domains frequently contain other interaction modules, such as the SH3 domain. Hence, these proteins serve as a scaffold for the assembly of different polypeptides into macromolecular signaling complexes. Shaker-type potassium channels and N-methyl-D-aspartate (NMDA) receptors have been identified as proteins that interact with the PDZ domains of PSD-95 (17, 28, 34). These investigators characterized a short COOH-terminal end motif (tS/T-X-V), which is necessary for the binding of NMDA receptors and Shaker-like channels to PDZ domains. The binding to PDZ domains determines the subcellular localization and the clustering of these polypeptides in neurons (14, 15, 17). Additional members of the PSD-95 family have been implicated in the formation of synaptic complexes (4, 5, 16, 27).
Of the different channel types expressed in cardiac myocytes, potassium channels are the most diverse. These channels participate in determining the resting membrane potential, the action potential duration, the duration of the refractory period, and the automaticity (9). The regional and cell-specific distribution of these channels contributes to regional variations in shape and duration of the action potential in the heart (2, 9). Very little is known about the mechanisms that regulate the targeting of cardiac Kv channels to specific sites of the plasma membrane. Two recent studies addressed the membrane distribution of these polypeptides. Mays et al. (26) showed that Kv1.5 was localized to the intercalated disks of human atrial and ventricular myocytes. Barry et al. (3) showed a clear membrane distribution of Kv1.5, Kv1.2, Kv2.1, and Kv4.2 channel polypeptides with high staining intensity at the intercalated disks of rat cardiocytes. However, in contrast with neuronal cells, the mechanisms underlying the targeting and localization of Kv channels to the intercalated disks of cardiac myocytes have not been elucidated. Here we show that SAP97 colocalizes with Kv1.5 channel polypeptides in cardiac myocytes. It also coprecipitates and colocalizes with it in a COS-7 cell heterologous expression system. Furthermore, SAP97 enhances Kv1.5-encoded currents in coinjection experiments using Xenopus oocytes. The results suggest that SAP97 may play an important role in determining the plasma membrane expression and distribution of Kv1.5 in cardiac myocytes.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cloning, cell culture, and transfection. Rat SAP97 cDNA was subcloned into pCDNA3 as an EcoRI/EcoRI fragment and ZO-1 cDNA was subcloned into pCDNA3 as an EcoRI/ApaI fragment. Kv1.1 (20) and Kv1.5 (24) cDNAs were subcloned as HindIII/BamHI or BstEIV/ApaI fragments in pCDNA3 with a FLAG tag at the NH2 terminus. The FLAG epitope-tagged Kv1.5 A-A-A (FL-Kv1.5-A) mutant was generated by polymerase chain reaction (PCR) using the following primers: forward, 5'-GCCGATCCATTCTTCATCGTGGAGACC-3'; and reverse, 5'-CGCGGATCCTTACGCAGCAGCTTCACGGCTAGTGTCCAG-3'; and a 0.75-kb ClaI/BamHI fragment from the PCR product was used to replace an equivalent fragment in wild-type FL-Kv1.5 cDNA. COS-7 cells were cultured in Dulbecco's modified Eagle's medium containing 10% fetal calf serum at 37°C in a 5% CO2 incubator. Transient transfection experiments were performed as described previously (23).
Immunocytochemistry. Adult rat ventricular myocytes were prepared as described previously (35). Freshly isolated cardiocytes or COS-7 cells were fixed and permeabilized in 2% paraformaldehyde and 0.5% saponin in phosphate-buffered saline (PBS) (pH 7.4) for 30 min. The cells were postfixed in a 1:1 methanol-acetone mixture for 10 min and blocked with 5% BSA for 1 h. Cells were dual labeled with the primary antibodies in a sequential manner. The antibodies used were mouse monoclonal anti-PSD-95 family (Upstate Biotechnology), which may recognize several PDZ domain-containing proteins, including PSD-95, SAP-97, and chapsyn/PSD-93, affinity-purified rabbit polyclonal anti-SAP97 (a kind gift of Dr. M. Sheng), rabbit polyclonal anti-Kv1.5 (1), mouse monoclonal anti-BiP (Transduction Laboratories), and mouse monoclonal anti-N-cadherin (Transduction Laboratories). The secondary antibodies used were fluorescein isothiocyanate-conjugated goat anti-mouse or anti-rabbit and rhodamine-conjugated donkey anti-mouse or anti-rabbit IgGs.
Immunoprecipitation. Three to four days after the transfections, COS-7 cells were harvested with the use of a lysis buffer composed of (in mM) 150 NaCl, 10 Tris (pH 8.0), 0.5 EDTA, 1 iodoacetamide, and 1% Triton X-100 and a mixture of protease inhibitors. The immunoprecipitation experiments were carried out as described previously (23). The immunopellets were electrophoresed in 8% sodium dodecyl sulfate-polyacrylamide gels (SDS-PAGE), blotted onto PVDF membranes, and probed with the following antibodies: anti-PSD-95, anti-SAP97, rabbit polyclonal anti-ZO-1 antibody (Zymed), rabbit polyclonal anti-Kv1.5 antibody, or mouse monoclonal anti-FLAG (Sigma). Crude membrane and cytosol fractions were prepared from mouse heart ventricles by differential centrifugation. With the use of a Polytron, ventricles were homogenized in Tris-EDTA buffer (pH 7.4) with 1 mM iodoacetamide and a cocktail of protease inhibitors. Debris was pelleted by centrifugation at 1,000 g and the supernatant was spun at 40,000 g for 1 h. The crude membrane pellet was washed once and dissolved in Triton lysis buffer.
Electrophysiological studies.
Xenopus oocytes were harvested from mature Xenopus
laevis females and dissociated in Ca2+-free Barth's
solution containing 1 mg/ml type II collagenase (Worthington). Isolated
follicle-free stage 5 and 6 oocytes were selected
and injected with different amounts of cRNAs. For coexpression experiments, Kv1.5 cRNA was mixed with either
SAP97 or ZO-1 cRNAs before injections. The total
volume of the cRNAs injected was constant (46 nl) in each group to
minimize the variation resulting from on-site leakage. The injected
oocytes were maintained at 18-19°C in Barth's solution. The
Barth's solution, supplemented with penicillin (100 U/ml) and
streptomycin (100 µg/ml), contained (in mM) 88 NaCl, 1.0 KCl, 2.4 NaHCO3, 0.3 Ca(NO3)2, 0.41 CaCl2, 0.82 MgSO4, 15 HEPES, and 5 sodium
pyruvate, pH 7.6. Kv1.5-encoded currents were measured with a
two-microelectrode voltage clamp using a GeneClamp amplifier (model
500, Axon Instruments) controlled by pCLAMP software (version 6.0.4, Axon Instruments) through a Digidata interface (model 1200, Axon
Instruments). The bath solution contained (in mM) 96 NaCl, 2 KCl, 0.5 CaCl2, 0.5 MgCl2, and 10 HEPES, pH 7.5. Currents were elicited by a series of depolarization pulses from the
holding potential of
70 to +60 mV with an increment of 10 mV for 200 ms, followed by a repolarization to
40 mV to elicit the tail
currents. A P/4 leakage substraction protocol was used to minimize the
leakage and capacitative currents. Data were expressed as means ± SD. Student's t-test and analysis of variance were used to
evaluate the statistical significance.
| |
RESULTS |
|---|
|
|
|---|
Colocalization of SAP97 and Kv1.5 in cardiac myocytes.
The involvement of PSD-95 and other PDZ domain-containing proteins in
the assembly of macromolecular signaling complexes in neurons has
been clearly established. By contrast, very little is known about the
formation, molecular composition, and targeting of signaling complexes
containing K+ channels in cardiac tissue. SAP97, a PDZ
domain-containing protein abundantly expressed in the heart, was shown
to interact with Shaker-like K+ channels in heterologous
systems. We used immunocytochemistry to study the membrane distribution
of SAP97 and Kv1.5 in cardiac myocytes using anti-SAP97, anti-PSD-95,
and anti-Kv1.5 antibodies. Control experiments using preimmune
serum, rabbit IgG, isotype-specific mouse IgG, or secondary antibodies
did not show significant staining under the experimental conditions
used. Experiments using affinity-purified anti-SAP97 antibody revealed
that SAP97 is expressed at both the intercalated disks and the lateral
membranes (Fig.
1A). A
similar distribution was observed using the monoclonal anti-PSD-95
antibody (Fig. 1K), although the background staining with
this antibody was higher. The distribution pattern of SAP97 differed
from that of ZO-1, another PDZ domain-containing protein expressed in
the heart: ZO-1 localized primarily to the intercalated disks, with no
staining detectable in lateral membranes (not shown). More importantly,
the staining with anti-Kv1.5 antibody revealed that the membrane
distribution of this channel was similar to that of SAP97: the
immunoreactive Kv1.5 polypeptide was detectable both at the
intercalated disks and the lateral membranes (Fig. 1D). To
further prove that the distribution of Kv1.5 and SAP97 includes both
the intercalated disks and the lateral membrane, we costained cardiac
myocytes with anti-N-cadherin and either anti-Kv1.5 or anti-SAP97
antibodies. The results showed that, whereas the N-cadherin antibody
stained only the intercalated disks (Fig. 1, B,
E, and H), SAP97 and Kv1.5 immunoreactive
polypeptides were detected both in the intercalated disks and lateral
membranes (Fig. 1, A, C, D, and
F). Interestingly, Z-series confocal microscopy revealed a
patchy distribution of Kv1.5 on the cell surface that clearly differs
from that of N-cadherin (Fig. 1, G-I). To
further prove the colocalization of SAP97 and Kv1.5, we performed
costaining experiments using rabbit polyclonal anti-Kv1.5 and mouse
monoclonal anti PSD-95 antibodies. The results (Fig. 1,
J-L) confirmed the colocalization of Kv1.5
and SAP97 in cardiac myocytes. Although anti-PSD95 cross-reacts with
additional PDZ domain-containing proteins, we had to use this antibody
because the monoclonal anti-Kv1.5 antibody failed to detect Kv1.5 in
cardiac myocytes. Taken together, these experiments revealed
codistribution of Kv1.5 and SAP 97 in the lateral membranes and the
intercalated disks.
|
Biochemical and immunocytochemical evidence for interactions of
FL-Kv1.5 with SAP97.
We then investigated whether SAP97 and Kv1.5 interact in vivo. We were
unable to consistently detect this interaction in coimmunoprecipitation experiments from heart extracts, presumably because of the low level of
expression of Kv1.5. Thus we decided to examine the Kv1.5-SAP97 interaction in overexpression experiments in COS-7 cells, using SAP97 and NH2-terminal FL-Kv1.5 cDNAs
subcloned into pCDNA3. Initially, the cells were transfected with
SAP97 cDNA and the cell lysates were precipitated with
anti-PSD-95 family antibody (anti-PSD-95). To determine the specificity
of this antibody in COS-7 cells, the immunoprecipitates were size
separated and immunoblotted with either anti-PSD-95 or an
affinity-purified rabbit polyclonal anti-SAP97 antibody. Anti-PSD-95
antibody reacted with two ~120-kDa polypeptides in transfected COS-7
cells (Fig. 2A, lane
2), but it did not react with the ZO-1 polypeptides (Fig.
2A, lane 3). Importantly, affinity-purified anti-SAP97 antibody reacted with the same two 120-kDa polypeptides (Fig. 2A, lane 5), confirming the observation of
Kim et al. (16) that SAP97 cDNA transfected
into COS-7 cells codes for polypeptides with an apparent molecular mass
of 120 kDa. The second band is likely due to posttranslational
modifications of SAP97. Western blot analysis of cardiac cell lysates
revealed that anti-PSD-95 antibody also reacted with two polypeptides
with apparent molecular mass of ~120 kDa, identical to those of SAP97
expressed in COS-7 cells (Fig. 2B, lanes
1-3). Differential centrifugation of heart extracts revealed that most of the SAP97 polypeptides segregated to the
crude membrane fraction (Fig. 2C, lane 2) rather
than the cytosol (Fig. 1C, lane 1).
|
|
|
|
Coexpression of SAP97 and FL-Kv1.5 enhances Kv1.5-encoded currents
in Xenopus oocytes.
We next investigated the functional effects of the interaction of SAP97
and Kv1.5. Transient transfection experiments in COS-7 cells are not
adequate for this purpose because of the impossibility of accurately
determining the SAP97/Kv1.5 expression ratio in each cell. Also, most
of the SAP97 and Kv1.5 polypeptides are retained in the ER and thus are
not suitable for electrophysiological studies. Therefore, to assess the
functional effects of the interaction of SAP97 and Kv1.5, we carried
out coinjection experiments of FL-Kv1.5 with either
SAP97 or ZO-1 cRNAs into Xenopus
oocytes. To ensure the validity of the results, we first measured the
amplitude of the Kv1.5-encoded outward currents in oocytes injected
with 4 (not shown), 8, and 16 fmol of FL-Kv1.5 cRNAs. As
shown in Fig. 6A, the
linearity of the current was maintained fairly well at different
voltages with the amount of cRNA tested. Based on these results, 8 fmol
of FL-Kv1.5 cRNA was used in coinjection experiments. Oocytes injected with FL-Kv1.5 cRNA expressed rapidly
activating and slowly inactivating outward potassium current (Fig.
6B). Coinjection of SAP97 with
FL-Kv1.5 resulted in a statistically significant twofold
increase in the steady-state levels of the Kv1.5-encoded currents (Fig.
6, B and C). A similar increase was
observed in two additional batches of oocytes coinjected, respectively,
with 2:4 and 4:4 fmol of Kv1.5 to SAP97 cRNAs. However,
in one batch of oocytes, which expressed exceptionally high levels of
currents, the coinjection of SAP97 at 4:8 and 8:8 fmol
failed to enhance the Kv1.5-encoded currents, although the 4:4 ratio
did. Thus it appears that the enhancing effect of SAP97 is sensitive to
the initial level of expression of Kv1.5: the lower the Kv1.5-encoded currents, the more pronounced the enhancing effect. In all coinjection groups, the maximum relative conductance
(G/Gmax, Fig. 5D), voltage dependence, and kinetics of activation (data not shown) of the currents
remained similar to those of the control group. In contrast with the
observed effect of SAP97, the coinjection of ZO-1 cRNA caused either no
change or even a slight decrease in the amount of Kv1.5-encoded
currents (Fig. 6, B and C). These results, which are in agreement with the lack of interaction of ZO-1 with Kv1.5 in
transfection experiments (see above), suggest that SAP97, but not ZO-1,
is able to modulate the expression of Kv1.5.
|
| |
DISCUSSION |
|---|
|
|
|---|
The targeting of ion channels to discrete plasma membrane domains of cardiac myocytes is critical to cardiac cell excitation. PDZ domain-containing proteins have been shown to play an important role in the targeting of sodium channels, NMDA receptors, and voltage-gated potassium channels to discrete plasma membrane domains in neuronal cells (8, 29, 30), but very little is known about the function of this family of proteins in the organization of macromolecular signaling complexes in the heart. Recent studies (33) in cardiac myocytes revealed that the gap junction protein connexin43 associates with ZO-1 at the intercalated disks and that the overexpression of dominant negative mutants of ZO-1 abolishes the formation of recombinant gap junctions.
In this study, we have demonstrated that SAP97, a PDZ domain-containing protein abundantly expressed in the heart, localizes to the intercalated disks and the lateral membranes of adult cardiac myocytes. This plasma membrane distribution is identical to that of Kv1.5, which suggests that Kv1.5 and SAP97 may interact in cardiac tissue. However, we were unable to demonstrate this interaction in coimmunoprecipitation experiments from cardiac cell lysates because of the low level of expression of Kv1.5 in the heart. Thus we used transient transfection experiments in COS-7 cells to demonstrate the association of Kv1.5 with SAP97. Furthermore, we show that this interaction is specific, because a T-D-L to A-A-A mutation at the COOH-terminus of Kv1.5 abolished its association with SAP97. Although the tE-T-D-L COOH terminal sequence of Kv1.5 differs from the tS/T-X-V consensus motif defined by Sheng and others (17, 31), studies on the interaction of PSD-95 with the COOH-terminus of Kir2.3 (tE-S-A-I) demonstrated that its PDZ domains do accommodate a leucine residue at the COOH-terminus (7). Moreover, SAP97/hDlg has been shown to associate with adenomotous Polyposis coli, human papillomavirus E6, and adenovirus type 9 E4, allowing the SAP97 COOH-terminal consensus binding motif to be extended to tX-S/T-X-V/I/L (19, 22, 25).
Although our cotransfection experiments in COS-7 cells clearly demonstrated the specific association of SAP97 and Kv1.5, the immunocytochemical analysis of cotransfected COS-7 cells showed that the majority of SAP97 and Kv1.5 polypeptides were localized in the ER, with minimal accumulation on the cell membrane. This distribution, which resembles that reported (32) for other Kv1 channels in similar overexpression systems, differs from the plasma membrane localization of endogenous SAP97 and Kv1.5 in cardiac myocytes and probably reflects the inability of COS-7 cells to target high levels of exogenously expressed proteins to their proper intracellular destinations. Thus we used a different expression system to investigate the functional consequences of the interaction of Kv1.5 and SAP97. As shown in Fig. 6, we demonstrated that the coinjection of Kv1.5 with SAP97, but not with ZO-1, into Xenopus oocytes resulted in a significant increase of the steady-state levels of Kv1.5-encoded currents. Recently, Burke et al. (6) showed that the interaction between PSD-95 and Kv1.4 in oocytes leads to the immobilization of Kv1.4 channels in the plasma membrane. Thus the channel clusters formed in the presence of PSD-95 were stable in size, shape, and position (6). We hypothesize that the enhancement of the whole cell Kv1.5-encoded currents in oocytes by SAP97 may occur by a similar mechanism, involving the recruitment or retention of more functional channels (and/or channel-modulating proteins) to the membranes, rather than increasing the channel open probability or unitary conductance. Indeed, this model is supported by recent observations by Horio et al. (13), who showed that the coexpression of SAP97 and the Kir channel in oocytes enhanced the Kir-encoded current without changing the single channel conductance or open probability.
The level of expression and proper distribution of voltage-gated potassium channels are crucial for determining the shape and duration of the action potential and the refractoriness of cardiac myocytes (2, 9). PDZ domain-containing proteins have emerged as an important group of scaffolding proteins that interact with ion channels, receptors, and their modulators (8, 29). In this study, we have demonstrated that SAP97 interacts with Kv1.5 in heterologous expression systems and colocalizes with it in cardiac myocytes. Further studies are needed to elucidate the exact nature of these interactions and their functional significance as related to outward potassium currents expressed in the heart.
| |
ACKNOWLEDGEMENTS |
|---|
We thank Momoyo Murata and Ming-Ying Pu for excellent technical support. We also thank M. Wyszynski and M. Sheng for the generous gift of anti-SAP97 antibody and the rat SAP97 cDNA, S. Ryeom and D. A. Goodenough for the ZO-1 cDNA and the rat anti-ZO-1 antibody, M. Seki for pcDNA3 with a FLAG epitope, and Y. Kim for the Marathon cDNA library.
| |
FOOTNOTES |
|---|
* P. D. Buckett and J. Zhou contributed equally to this work.
G. Koren is a recipient of National Heart, Lung, and Blood Institute Grant HL-46005 and an Established Investigator Award from the American Heart Association. M. Murata is a recipient of a postdoctoral Fellowships Award from the Japan Heart Foundation.
Address for reprint requests and other correspondence: G. Koren, Cardiovascular Div., Brigham and Women's Hosp., 75 Francis St., Boston, MA 02115 (E-mail: koren{at}calvin.bwh.harvard.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 25 May 2001; accepted in final form 8 August 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Babila, T,
Moscucci A,
Wang H,
Weaver FE,
and
Koren G.
Assembly of mammalian voltage-gated potassium channels: evidence for an important role of the first transmembrane segment.
Neuron
12:
615-626,
1994[ISI][Medline].
2.
Barry, DM,
and
Nerbonne JM.
Myocardial potassium channels: electrophysiological and molecular diversity.
Annu Rev Physiol
58:
363-394,
1996[ISI][Medline].
3.
Barry, DM,
Trimmer JS,
Merlie JP,
and
Nerbonne JM.
Differential expression of voltage-gated K+ channel subunits in adult rat heart. Relation to functional K+ channels?
Circ Res
77:
361-369,
1995
4.
Brenman, JE,
Chao DS,
Gee SH,
McGee AW,
Craven SE,
Santillano DR,
Wu Z,
Huang F,
Xia H,
Peters MF,
Froehner SC,
and
Bredt DS.
Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and
1-syntrophin mediated by PDZ domains.
Cell
84:
757-767,
1996[ISI][Medline].
5.
Budnik, V,
Koh YH,
Guan B,
Hartmann B,
Hough C,
Woods D,
and
Gorczyca M.
Regulation of synapse structure and function by the Drosophila tumor suppressor gene Dlg.
Neuron
17:
627-640,
1996[ISI][Medline].
6.
Burke, NA,
Takimoto K,
Li D,
Han W,
Watkins SC,
and
Levitan ES.
Distinct structural requirements for clustering and immobilization of K+ channels by PSD-95.
J Gen Physiol
113:
71-80,
1999
7.
Cohen, NA,
Brenman JE,
Snyder SH,
and
Bredt DS.
Binding of the inward rectifier K+ channel Kir 2.3 to PSD-95 is regulated by protein kinase A phosphorylation.
Neuron
17:
759-767,
1996[ISI][Medline].
8.
Craven, SE,
and
Bredt DS.
PDZ proteins organize synaptic signaling pathways.
Cell
93:
495-498,
1998[ISI][Medline].
9.
Deal, KK,
England SK,
and
Tamkun MM.
Molecular physiology of cardiac potassium channels.
Physiol Rev
76:
49-67,
1996
10.
Folco, E,
Mathur R,
Mori Y,
Buckett P,
and
Koren G.
A cellular model for long QT syndrome. Trapping of heteromultimeric complexes consisting of truncated Kv11 potassium channel polypeptides and native Kv14 and Kv15 channels in the endoplasmic reticulum.
J Biol Chem
272:
26505-26510,
1997
11.
Garner, CC,
Nash J,
and
Huganir RL.
PDZ domains in synapse assembly and signalling.
Trends Cell Biol
10:
274-280,
2000[ISI][Medline].
12.
Harrison, SC.
Peptide-surface association: the case of PDZ and PTB domains.
Cell
86:
341-343,
1996[ISI][Medline].
13.
Horio, Y,
Hibino H,
Inanobe A,
Yamada M,
Ishii M,
Tada Y,
Satoh E,
Hata Y,
Takai Y,
and
Kurachi Y.
Clustering and enhanced activity of an inwardly rectifying potassium channel, Kir4.1, by an anchoring protein, PSD-95/SAP90.
J Biol Chem
272:
12885-12888,
1997
14.
Hsueh, YP,
Kim E,
and
Sheng M.
Disulfide-linked head-to-head multimerization in the mechanism of ion channel clustering by PSD-95.
Neuron
18:
803-814,
1997[ISI][Medline].
15.
Hsueh, YP,
and
Sheng M.
Requirement of N-terminal cysteines of PSD-95 for PSD-95 multimerization and ternary complex formation, but not for binding to potassium channel Kv1.4.
J Biol Chem
274:
532-536,
1999
16.
Kim, E,
Cho KO,
Rothschild A,
and
Sheng M.
Heteromultimerization and NMDA receptor-clustering activity of Chapsyn-110, a member of the PSD-95 family of proteins.
Neuron
17:
103-113,
1996[ISI][Medline].
17.
Kim, E,
Niethammer M,
Rothschild A,
Jan YN,
and
Sheng M.
Clustering of Shaker-type K+ channels by interaction with a family of membrane-associated guanylate kinases.
Nature
378:
85-88,
1995[Medline].
18.
Kim, E,
and
Sheng M.
Differential K+ channel clustering activity of PSD-95 and SAP97, two related membrane-associated putative guanylate kinases.
Neuropharmacology
35:
993-1000,
1996[ISI][Medline].
19.
Kiyono, T,
Hiraiwa A,
Fujita M,
Hayashi Y,
Akiyama T,
and
Ishibashi M.
Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein.
Proc Natl Acad Sci USA
94:
11612-11616,
1997
20.
Koren, G,
Liman ER,
Logothetis DE,
Nadal-Ginard B,
and
Hess P.
Gating mechanism of a cloned potassium channel expressed in frog oocytes and mammalian cells.
Neuron
4:
39-51,
1990[ISI][Medline].
21.
Kuriyan, J,
and
Cowburn D.
Modular peptide recognition domains in eukaryotic signaling.
Annu Rev Biophys Biomol Struct
26:
259-288,
1997[ISI][Medline].
22.
Lee, SS,
Weiss RS,
and
Javier RT.
Binding of human virus oncoproteins to hDlg/SAP97, a mammalian homolog of the Drosophila discs large tumor suppressor protein.
Proc Natl Acad Sci USA
94:
6670-6675,
1997
23.
Mathur, R,
Zhou J,
Babila T,
and
Koren G.
Ile-177 and Ser-180 in the S1 segment are critically important in Kv1.1 channel function.
J Biol Chem
274:
11487-11493,
1999
24.
Matsubara, H,
Liman ER,
Hess P,
and
Koren G.
Pretranslational mechanisms determine the type of potassium channels expressed in the rat skeletal and cardiac muscles.
J Biol Chem
266:
13324-13328,
1991
25.
Matsumine, A,
Ogai A,
Senda T,
Okumura N,
Satoh K,
Baeg GH,
Kawahara T,
Kobayashi S,
Okada M,
Toyoshima K,
and
Akiyama T.
Binding of APC to the human homolog of the Drosophila discs large tumor suppressor protein.
Science
272:
1020-1023,
1996[Abstract].
26.
Mays, DJ,
Foose JM,
Philipson LH,
and
Tamkun MM.
Localization of the Kv1.5 K+ channel protein in explanted cardiac tissue.
J Clin Invest
96:
282-292,
1995.
27.
Muller, BM,
Kistner U,
Kindler S,
Chung WJ,
Kuhlendahl S,
Fenster SD,
Lau LF,
Veh RW,
Huganir RL,
Gundelfinger ED,
and
Garner CC.
SAP102, a novel postsynaptic protein that interacts with NMDA receptor complexes in vivo.
Neuron
17:
255-265,
1996[ISI][Medline].
28.
Niethammer, M,
Kim E,
and
Sheng M.
Interaction between the C terminus of NMDA receptor subunits and multiple members of the PSD-95 family of membrane-associated guanylate kinases.
J Neurosci
16:
2157-2163,
1996
29.
Pawson, T,
and
Scott JD.
Signaling through scaffold, anchoring, and adaptor proteins.
Science
278:
2075-2080,
1997
30.
Schultz, J,
Hoffmuller U,
Krause G,
Ashurst J,
Macias MJ,
Schmieder P,
Schneider-Mergener J,
and
Oschkinat H.
Specific interactions between the syntrophin PDZ domain and voltage-gated sodium channels.
Nat Struct Biol
5:
19-24,
1998[ISI][Medline].
31.
Songyang, Z,
Fanning AS,
Fu C,
Xu J,
Marfatia SM,
Chishti AH,
Crompton A,
Chan AC,
Anderson JM,
and
Cantley LC.
Recognition of unique carboxyl-terminal motifs by distinct PDZ domains.
Science
275:
73-77,
1997
32.
Tiffany, AM,
Manganas LN,
Kim E,
Hsueh YP,
Sheng M,
and
Trimmer JS.
PSD-95 and SAP97 exhibit distinct mechanisms for regulating K(+) channel surface expression and clustering.
J Cell Biol
148:
147-158,
2000
33.
Toyofuku, T,
Yabuki M,
Otsu K,
Kuzuya T,
Hori M,
and
Tada M.
Direct association of the gap junction protein connexin-43 with ZO-1 in cardiac myocytes.
J Biol Chem
273:
12725-12731,
1998
34.
Wyszynski, M,
Lin J,
Rao A,
Nigh E,
Beggs AH,
Craig AM,
and
Sheng M.
Competitive binding of alpha-actinin and calmodulin to the NMDA receptor.
Nature
385:
439-442,
1997[Medline].
35.
Zhou, J,
Jeron A,
London B,
Han X,
and
Koren G.
Characterization of a slowly inactivating outward current in adult mouse ventricular myocytes.
Circ Res
83:
806-814,
1998
This article has been cited by other articles:
![]() |
T. K. Roepke, A. Kontogeorgis, C. Ovanez, X. Xu, J. B. Young, K. Purtell, P. A. Goldstein, D. J. Christini, N. S. Peters, F. G. Akar, et al. Targeted deletion of kcne2 impairs ventricular repolarization via disruption of IK,slow1 and Ito,f FASEB J, October 1, 2008; 22(10): 3648 - 3660. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Jindal, E. J. Folco, G. X. Liu, and G. Koren Posttranslational modification of voltage-dependent potassium channel Kv1.5: COOH-terminal palmitoylation modulates its biological properties Am J Physiol Heart Circ Physiol, May 1, 2008; 294(5): H2012 - H2021. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Abi-Char, S. El-Haou, E. Balse, N. Neyroud, R. Vranckx, A. Coulombe, and S. N. Hatem The anchoring protein SAP97 retains Kv1.5 channels in the plasma membrane of cardiac myocytes Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1851 - H1861. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-J. L.H.J. Aarnoudse, C. Newton-Cheh, P. I.W. de Bakker, S. M.J.M. Straus, J. A. Kors, A. Hofman, A. G. Uitterlinden, J. C.M. Witteman, and B. H.C. Stricker Common NOS1AP Variants Are Associated With a Prolonged QTc Interval in the Rotterdam Study Circulation, July 3, 2007; 116(1): 10 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. F. Steele, J. Eldstrom, and D. Fedida Mechanisms of cardiac potassium channel trafficking J. Physiol., July 1, 2007; 582(1): 17 - 26. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. J. Folco, G.-X. Liu, and G. Koren Caveolin-3 and SAP97 form a scaffolding protein complex that regulates the voltage-gated potassium channel Kv1.5 Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H681 - H690. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Xiang, E. Devic, and B. Kobilka The PDZ Binding Motif of the beta 1 Adrenergic Receptor Modulates Receptor Trafficking and Signaling in Cardiac Myocytes J. Biol. Chem., September 6, 2002; 277(37): 33783 - 33790. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |